Markets:

Overview

News

Currencies

International

Treasuries

United Therapeutics Corporation - Common Stock (NQ:UTHR)

564.12 +0.19 (+0.03%)

Streaming Delayed Price Updated: 1:32 PM EDT, May 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about United Therapeutics Corporation - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

United Therapeutics Unveils Net Zero Energy Distribution Center

June 14, 2023

From United Therapeutics Corporation

Via Business Wire

Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

May 18, 2023

These two mid-cap biotech companies are relatively established in their fields — but according to analysts, still have significant upside.

Via MarketBeat

United Therapeutics's Return On Capital Employed Insights ↗

May 10, 2023

Via Benzinga

The Latest Analyst Ratings for United Therapeutics ↗

May 04, 2023

Via Benzinga

Why United Therapeutics Shares Are Falling Today ↗

May 03, 2023

United Therapeutics Corporation's (NASDAQ: UTHR) Q1 revenues grew 10% Y/Y to $506.9 million, missing the

Via Benzinga

Recap: United Therapeutics Q1 Earnings ↗

May 03, 2023

Via Benzinga

Analyst Expectations for United Therapeutics's Future ↗

April 10, 2023

Via Benzinga

This Foreboding Sign Looms Over United Therapeutics's Chart ↗

April 05, 2023

Via Benzinga

Earnings Outlook For United Therapeutics ↗

February 21, 2023

Via Benzinga

United Therapeutics Corporation Reports First Quarter 2023 Financial Results

May 03, 2023

From United Therapeutics Corporation

Via Business Wire

United Therapeutics Corporation to Report First Quarter 2023 Financial Results Before the Market Opens on Wednesday, May 3, 2023

April 26, 2023

From United Therapeutics Corporation

Via Business Wire

7 Biotech Stocks That Could Cure Your Portfolio Woes ↗

April 19, 2023

If you want to revitalize your portfolio with some exciting opportunities, these biotech stocks to buy might fit the bill.

Via InvestorPlace

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at Upcoming Scientific Meetings

April 18, 2023

From United Therapeutics Corporation

Via Business Wire

Analyst Ratings for United Therapeutics ↗

January 11, 2023

Via Benzinga

Morgan Stanley Maintains Overweight Rating for United Therapeutics: Here's What You Need To Know ↗

December 06, 2022

Via Benzinga

United Therapeutics Corporation to Present at the Oppenheimer 33rd Annual Healthcare Conference

March 06, 2023

From United Therapeutics Corporation

Via Business Wire

United Therapeutics Corporation to Present at the Cowen 43rd Annual Health Care Conference

February 28, 2023

From United Therapeutics Corporation

Via Business Wire

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2022 Financial Results

February 22, 2023

From United Therapeutics Corporation

Via Business Wire

United Therapeutics Corporation to Report Fourth Quarter and Full Year 2022 Financial Results Before the Market Opens on Wednesday, February 22, 2023

February 15, 2023

From United Therapeutics Corporation

Via Business Wire

Earnings Scheduled For February 22, 2023 ↗

February 22, 2023

Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022.

Via Benzinga

Want To Copy 'Master Trader' Nancy Pelosi's Investments? There's An ETF For That. Here Are The Holdings ↗

February 07, 2023

Subversive Capital launched two new ETFs Tuesday that offer investors the chance to mirror the trades being made by members of Congress.

Via Benzinga

3 Biotech Companies to Watch in 2023 ↗

January 06, 2023

These biotech companies to watch are remarkably strong businesses that offer healthy upside potential as we head into a new year.

Via InvestorPlace

Crocs, Lamb Weston And These 3 Stocks Insiders Are Selling ↗

January 06, 2023

The Nasdaq Composite dropped around 150 points on Thursday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Alphabet And These 2 Healthcare Stocks Insiders Are Selling ↗

January 04, 2023

The Nasdaq Composite dropped around 80 points on the first trading day of 2023. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

United Therapeutics Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 02, 2023

From United Therapeutics Corporation

Via Business Wire

Should SMLF Be On Your Investing Radar? ↗

December 26, 2022

Sitting at a market capitalization below $2 billion, small cap companies tend to be high-potential stocks compared to their large and mid-cap counterparts but come with higher risks.

Via Talk Markets

Buy/Sell: Wall Street's Top 10 Stock Calls This Week - Saturday, Dec. 10 ↗

December 10, 2022

What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street’s best analysts during the week of Dec. 5-9, 2022.

Via Talk Markets

Our 7 Top Biotech Stock Picks for 2023 ↗

December 09, 2022

Following the devastation of Covid-19, there’s greater interest toward medical innovations, thus bolstering biotech stock picks for 2023.

Via InvestorPlace

United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2023

December 08, 2022

From United Therapeutics Corporation

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022 ↗

December 06, 2022

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.